Connect with us

Business

CDC expert panel punts on deciding fate of J&J COVID vaccine – Ars Technica

Experts brace for more clotting cases as 52% of doses were given in the last 2 weeks.

Published

on

Article feature image
ADVERTISEMENT

Enlarge/ Boxes of Johnson & Johnson’s Janssen COVID-19 vaccine at a vaccination site in Florida.
76 with 52 posters participating
View more stories
An advisory committee for the Centers for Disease Control and Prevention declined to vote on the fate of Johnson & Johnsons COVID-19 vaccine Wednesday, likely leaving in place a pause on the vaccines use until the committee reconvenes in seven to 10 days.
The CDCs Advisory Committee on Immunization Practices, or ACIP, expects that the coming week or…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
SpaceX’s Starlink internet satellites to connect with Google Cloud systems – Space.com
Article feature image
Pipeline attacker Darkside suddenly goes dark—here’s what we know – Ars Technica
Article feature image
Tesla Model X Deliveries Pushed Back From February To October – InsideEVs